Gabriel Leung
Exec. VP, Pres., (OSI) Onc., OSI PHARMACEUTICALS INC.
Companies
- NovoCure LtdBoard member Oct 1, 2015 to now1
- Pernix Therapeutics HoldingsBoard member Nov 22, 2016 to May 23, 20182
- Delcath Systems, Inc.Board member Mar 31, 2011 to Jul 9, 20143
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- NovoCure Ltd NVCR101,109 shares4$1.5M at $14.88Jun 3, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 3, 2026Granted 11,610 shares of NovoCure Ltd4
- Jun 2, 2026Sold 2,945 shares at $15.77 of NovoCure Ltd5
- Jun 4, 2025Granted 11,215 shares of NovoCure Ltd6
- Jun 3, 2025Sold 999 shares at $17.31 of NovoCure Ltd7
- Jun 5, 2024Granted 4,053 shares of NovoCure Ltd8
- Jun 4, 2024Sold 964 shares at $23.89 of NovoCure Ltd8
- Jun 7, 2023Granted 3,853 shares of NovoCure Ltd9
- Jun 8, 2022Granted 2,427 shares of NovoCure Ltd10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNovoCure Ltd, Board member
- 2
- 3SEC EDGARDelcath Systems, Inc., Board member
- 4
- 5SEC EDGARForm 4 filed Jun 3, 2026
- 6SEC EDGARForm 4 filed Jun 6, 2025
- 7SEC EDGARForm 4 filed Jun 4, 2025
- 8SEC EDGARForm 4 filed Jun 6, 2024
- 9SEC EDGARForm 4 filed Jun 9, 2023
- 10SEC EDGARForm 4 filed Jun 10, 2022